T1	Outcomes 0 24	Safety and effectiveness
T2	Outcomes 1222 1238	median follow-up
T3	Outcomes 1368 1400	Median progression-free survival
T4	Outcomes 1456 1479	median overall survival
T5	Outcomes 1580 1631	Incidences of bevacizumab-associated adverse events
